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5-Methyl-2-n-ribobenzimidazole  (MRB) 1 restores  the capacity of the chorioallan- 
toic membranes from older chicken embryos to produce a large amount of influenza B 
(Lee) virus after a small inoculum (1, 2). The yield of both cell-associated and released 
virus  is  increased,  and  quantitation  by infectivity and  hemagglutination  titrations 
gives similar results.  MRB requires several hours to act. Once an effect has been es- 
tablished, the compound may be removed and an increase in virus yield still obtained 
many hours later, although there is a decay in the effect with time. Maximal enhance- 
ment is obtained when treatment of membrane cultures is begun before infection and 
continued for a prolonged period after infection. The available evidence suggests that 
MRB does not act through the interferon mechanism, but affects another restrictive 
mechanism that becomes operative in the course of embryological development  (2). 
This mechanism  is operative in normal cells  and,  unlike  the  interferon mechanism, 
does not require induction. 
It  appeared  desirable  to  determine  whether  derivatives  with  greater 
specific  and maximal  enhancing  activity  could be  found through  an  analysis 
of  structure-activity  relationships.  If found  and  demonstrated  to  possess  an 
action  similar  to  that  of  MRB,  such  compounds  would  be  highly  useful  in 
further studies of the mechanism of restriction of influenza virus multiplication. 
We report in the present communication that polyhydroxyalkyl-benzimida- 
zoles, varying in the side chain at position 2 in the imidazole ring or in the num- 
ber of methyl group substitutions  in the benzenoid ring,  do not show marked 
differences in enhancing activity. However, a new group of derivatives with in- 
creased virus-enhancing activity has been discovered and defined. These deriva- 
tives are characterized by the presence of a  hydroxyl or methoxyl grouping at 
position 5  and a  methyl grouping at position  1 in the benzimidazolyl nucleus. 
The action of 5-methoxy-l-methylbenzimidazole on influenza virus multiplica- 
tion has been examined in some detail and found to be similar to that of MRB. 
Materials and Methods 
Virus.--Influenza  B virus, Lee strain, was prepared and stored as described previously (1). 
Medium.--A balanced and buffered salts and glucose medium was used for maintenance of 
chorioallantoic membranes in vitro (1). 
* This investigation was supported by Research Grant AI-03445 from the National  Insti- 
tute of Allergy and Infectious Diseases, U.S. Public Health Service. 
1  Abbreviation used in this paper: MRB, 5-methyl-2-D-ribobenzimidazole. 
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Benzimidazole  Derivatives.--All  benzimidazole  derivatives  were  obtained  through  the 
courtesy of Merck, Sharp and Dohme Research Laboratories, Rahway, N. J. The compounds 
were  dissolved in the medium used for chorioallantoic membrane culture; shaking  at 37°C 
facilitated solution. 
Chorioallantoic Membrane Cultures.--In some experiments the virus-enhancing activity of 
benzimidazole derivatives was determined using the procedure described in 1956 (1). In most 
experiments the more recently described procedure for obtaining chorioallantoic membranes 
and for setting up cultures was used (2). According to either procedure, each culture that is set 
up contains membranes from a  group of embryos, and the results thus reflect the mean re- 
sponse of a randomly selected group of embryos. In addition, experiments were done in which 
cultures were set up with membranes from single embryos. These experiments reveal the re- 
sponses of individual embryos. 
Measurement of Virus  Yield.--The yield of virus in the culture medium was measured by 
hemagglutination using a fractional dilution procedure (1, 2). In some experiments yield was 
measured by a 50% infectivity end point titration procedure (3) ; the embryonated eggs were 
incubated for 72 h after inoculation. 
Determination of Toxicity of Compounds.--The  extent of macroscopic tissue damage caused 
by certain derivatives was estimated as described previously (4). This could be done in infected 
chorioallantoic membranes as Lee virus itself does not cause detectable morphological changes 
during incubation of membranes in vitro. 
RESULTS 
Polyhydroxyalkyl-benzimidazoles.--The  enhancing  activity  of  nine  poly- 
hydroxyalkyl-benzimidazoles was compared in chorioallantoic membranes from 
10-day old embryonated chicken eggs using the procedure described in 1956 (1). 
Membrane  portions  for  four  equivalent  groups  were  obtained  from  six  eggs 
selected  at  random.  In  each  experiment,  two  such  independent  sets  of  four 
cultures  were set up.  The effect of each compound  on influenza  B  (Lee)  virus 
yield was determined at several concentrations in two or three experiments,  and 
the concentration  giving 150 %  increase  in virus yield was  determined  graphi- 
cally (1).  The mean results obtained  with seven derivatives are summarized in 
Table I. As can be seen, no marked  differences in enhancing activity were ob- 
TABLE I 
Enhancing Activity of Polyhydroxyalkyl-benzimidazoles on Influenza B  (Lee) 
Virus Multiplication 
Concentration givin~  150% increase  Benzimidazole  derivative  in virus ymld* 
mM 
5-Methyl-2-D-ribo  1.5 
5,6-Dimethyl-2-D-ribo  1.5 
2-D-Gluco  1.9 
5-Methyl-2-D-gluco  1.6 
5,6-Dimethyl-2-D-gluco  1.8 
5-Methyl-2-D-galacto  1.6 
5-Methyl-2-L-rhamno  1.5 
* Membranes from 10-day old embryonated eggs were infected with Lee virus, 3  )<  104 
EID50/ml, and incubated for 41 h. Each value is based on two or three determinations. 860  ENHANCERS  OF  INFLUENZA  VIRUS  MULTIPLICATION 
served. No signs of morphological damage to the membranes (4) were noted at 
3.5 mM concentration of the derivatives listed in Table I. Two other derivatives 
were examined, i.e., 5-methyl-2-D-arabobenzimidazole and 5-methyl-2-D-man- 
nobenzimidazole. The solubility of these compounds was very low, but enhance- 
ment of the order of 100% was observed at 1.75 mM concentration of each, with 
considerable amounts  of undissolved  compound  present.  No  damage  to  the 
membranes was observed at this concentration. 
5-Methoxy- and 5-Ethoxybenzimidazoles.--In preliminary experiments using 
membranes from 10-day old embryonated eggs (1), the 5-methoxy and 5-ethoxy 
derivatives of benzimidazole increased Lee virus yield at  1.0 mM  concentra- 
tion, but decreased the yield at 3.5 mM  concentration. Variable results were 
obtained in the intervening range. Of the two compounds, 5-ethoxybenzimida- 
zole was considerably more active, both as an enhancer and an inhibitor. In- 
spection of the membranes (4) revealed toxic changes at concentrations above 
1.0 raM.  The degree of toxic changes varied directly with the concentration. 
5-Methoxybenzimidazole, 7.0 raM, and 5-ethoxybenzimidazole, 3.5 raM, caused 
marked  damage  (3+)  to  chorioallantoic  membranes.  For  comparison,  un- 
substituted  benzimidazole,  7.0  raM,  causes  only minimal  (4-)  macroscopic 
damage (4). 
Earlier studies have shown that substitution of a methyl group at position 1 
in  the  benzimidazolyl nucleus results  in  a  loss  of inhibitory activity for in- 
fluenza virus multiplication (5). While unsubstituted benzimidazole causes 75 % 
inhibition  of  virus  yield  at  3.5 mM  concentration,  1-methylbenzimidazole 
causes such an effect at 7.2 mM concentration. 
It was of great interest,  therefore, to determine whether substitution of a 
methyl group at position 1 in the benzimidazolyl nucleus in derivatives such as 
5-methoxybenzimidazole might  reduce  the  potential  for virus-inhibitory ac- 
tivity and  toxicity, and  thereby yield a  better enhancing compound. It  was 
found that  3.5 mM  5-methoxy-l-methylbenzimidazole is  nontoxic,  while 3.5 
mM  5-methoxybenzimidazole causes moderate damage.  Furthermore,  the  5- 
methoxy-l-methyl and related derivatives proved highly active as enhancers. 
5-Methoxy-  and  5-Hydroxy-  l-methylbenzimidazoles.--Comparative  experi- 
ments were  carried out with 5-methoxy-l-methylbenzimidazole and MRB  to 
determine the maximal  enhancement obtainable  with  each  and  the  concen- 
trations required, and also the concentrations giving equivalent enhancement. 
These experiments were carried out in membranes from  13-day old  embryo- 
nated eggs using the procedure in which membrane portions for nine equivalent 
groups are obtained from 12 eggs selected at random for each experiment (2). 
Fig. 1 shows that, on the basis of the molar concentration required for maxi- 
mal  enhancement,  5-methoxy-l-methylbenzimidazole is  approximately twice 
as active as MRB. The data recorded in Fig.  1 and results from other experi- 
ments  indicate  that  5-methoxy-l-methylbenzimidazole causes  maximal  en- 
hancement in the concentration range from 1.75 to 3.5 raM,  with 2.5 mM as IGOR  TAM'~  861 
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FIG. 1.  Relationship between  concentration of 5-methoxy-l-methylbenzimidazole and 5- 
methyl-2-D-ribobenzimidazole and degree of enhancement  of Lee virus multiplication. Cul- 
tures of chorioallantoic  membrane from  13-day old eggs were inoculated with Lee virus, 3 X 
104 EID~0/ml, and incubated for 41 h. Each culture contained 12 1.8 cm 2 pieces of membrane 
in 6 ml of medium. The inoculum was equivalent to 0.03 EIDs0 of virus per allantoic or chori- 
onlc cell on membrane surfaces. Yield was measured in the medium by hemagglutination ti- 
tration. The effects of the two compounds  were compared in the same experiment.  Mean re- 
sults of two experiments. 
the estimated peak concentration. The peak concentration fluctuates somewhat 
from  experiment  to  experiment,  which  reflects  biological  variation  in  the 
chorioallantoic membranes.  MRB  causes maximal enhancement  at a  concen- 
tration of 5.2 mM (Fig. 1 and ref. 2). The maximal enhancing effect obtainable 
with the 5-methoxy-l-methyl derivative is 1.4-fold greater than that obtainable 
with MRB.  Fig. 1 also shows that, on the basis of equivalent molar virus-en- 
hancing  concentrations,  5-methoxy-l-methylbenzimidazol  e  is  2.6  times  more 
active than MRB. 
The  effects  of  5-methoxy-l-methylbenzimidazole  (1.75 mM)  and  MRB 
(3.5 raM)  on  the yield of infective virus were also compared. Table II shows 
that both compounds increased the yield of infective virus and that the degree 
of enhancement  is  similar  as  measured  by infectivity and  hemagglutination 
titrations. 862  ENHANCERS  OF  INFLUENZA  VIRUS  MULTIPLICATION 
The 5-ethoxy-l-rnethyl derivative was not available, however examination of 
5-hydroxy-l-methylbenzimidazole showed  that  this  compound  is  even  more 
active than  the 5-methoxy-l-methyl derivative. As can be seen in Fig. 2,  the 
maximal enhancing effect of 5-hydroxy-l-methylbenzirnidazole (3.3 raM) is 2.4 
Enhancing  Effect 
TABLE II 
of  5-Methoxy-l-mahylbenzimidazole  and  5-Methyl-2-~-ribobenzimidazole 
(MRB) on the Production  of Infective Lee Virus 
Treatment of chorloallantoic  membrane 
Virus yield* 
EIDso/nfl  HAU/ml 
X 10  s 
None 
5-Methoxy-l-methylbenzimidazole, 1.75 mM 
5-Methyl-2-D-ribobenzimidazole  (MRB), 3.5 mM 
19  50 
280  400 
220  360 
* Membranes from  13-day old embryonated eggs were infected with Lee virus, 3  X  104 
EID~0/ml, and incubated for 41 h. 
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FIO. 2.  Relationship between  concentration of 5-hydroxy-l-methylbenzimidazole  and 5- 
methoxy-l-methylberszimidazole  and degree of enhancement  of Lee virus multiplication. For 
procedure see Fig. 1. Mean results of two experiments. IGOR TAMM  863 
times greater than that of 5-methoxy-l-methylbenzimidazole (2.5 mM). On the 
basis of estimated equivalent virus-enhancing concentrations, the 5-hydroxy-1- 
methyl derivative was 1.8-fold more active than the 5-methoxy-l-methyl com- 
pound in these experiments. Fig. 3 shows the results of separate experiments 
in which the effects of these compounds were compared in a lower concentration 
range.  The percent enhancement figures at the  1.75 mM concentration were 
lower in these experiments than in experiments summarized in Fig. 2,  again 
reflecting biological variation in the chicken embryos. In the experiments sum- 
marized in Fig. 3, 5-hydroxy-l-methylbenzimidazole  was 1.5 times more active 
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FI6. 3.  Relationship between concentration of 5-hydroxy-l-methylbenzimidazole  and 5- 
methoxy-l-methylbenzimidazole  and degree of enhancement  of Lee virus multiplication.  For 
procedure see Fig. 1. Mean results of two experiments. 
than  5-methoxy-l-methylbenzimidazole on  the  basis  of  equivalent  virus- 
enhancing concentrations. 
6-Methoxy- and  6-Hydroxy-l-methylbenzimidazoles.--A  comparison of  posi- 
tion 5-  vs. 6-substituted derivatives in Fig. 4 shows that while 6-hydroxy-1- 
methylbenzimidazole at 0.44 mM concentration has greater enhancing activity 
than the 5-hydroxy-l-methyl compound, maximal enhancement obtained with 
the 6-hydroxy-l-methyl derivative at higher concentrations is much less than 
that obtainable with the 5-hydroxy-l-methyl compound (Fig. 2).  The results 
in Fig. 5 provide confirmatory evidence that, at low concentrations 6-hydroxy- 
1-methylbenzimidazole shows greater enhancing activity than the 5-hydroxy- 
l-methyl compound.  The  6-methoxy-l-methyl derivative produces  maximal 864  ENHANCERS 0t"  INFLUENZA VIRUS MULTIPLICATION 
enhancement of a  low order at 0.11 mM concentration and it inhibits virus 
multiplication at 0.22 mM concentration. 
In  toxicity determinations  (4)  both  the  6-methoxy-l-methyl and  the  6- 
hydroxy-l-methyl derivative caused macroscopic morphological changes in the 
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FIO. 4.  Relationship between concentration of 5-hydroxy-l-methylbenzimidazole  and 6-hy- 
droxy-l-methylbenzimidazole  and degree of enhancement  of Lee virus multiplication.  For pro- 
cedure see Fig. 1. Mean results of two experiments. 
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FIG. 5.  Relationship  between  concentration  of  6-hydroxy-l-methylbenzimidazole,  5-hy- 
droxy-l-methylbenzimidazole,  and 6-methoxy-l-methylbenzimidazole  and degree of enhance- 
ment of Lee virus multiplication.  For procedure see Fig. 1. Mean results of three experiments. IGOR  TAMM  865 
membranes at a concentration of 3.5 mM (cf. Table III). 6-Methoxy-l-methyl- 
benzimidazole was somewhat more toxic than the 6-hydroxy-l-methyl deriva- 
tive.  In  contrast,  5-methoxy-l-methyl  and  5-hydroxy-l-methyl derivatives 
showed no toxicity. 
Additional Derivatives.--Three  additional derivatives have been examined: 
5-methoxy-1,2-dimethylbenzimidazole;  5-methoxy-l-fl-B-ribofuranosylbenzi- 
midazole;  and  6-methoxy-l-fl-D-ribofuranosylbenzimidazole. In  two  experi- 
ments with 5-methoxy-1,2-dimethylbenzimidazole, the mean control yield in 
membranes from 10-day old embryonated eggs was 32 hemagglutination units 
(HAU)/ml; at 3.5 mM concentration the compound caused 63 % inhibition of 
yield although no gross morphological evidence of damage  to the membrane 
was noted; at 1.75 mM concentration the yield was increased 210 %. Although 
the intrinsic  enhancing activity of the 5-methoxy-l,2-dimethyl derivative is 
TABLE III 
Toxicity of Enhancers of Lee Virus Multiplication in the Chorioallantoic Membrane 
Toxicity of benzimidazole derivatives* 
Concentration  5-Methoxy-  5-Hydroxy-  6-Methoxy-l-methyl  6-I-Iydroxy- 
l-methyl  1-methyl  1-methyl 
mM 
3.5  0  0  ++  to +++  ++ 
1.75  +  to ++  -4- 
0.9  ±  to + 
* Membranes from 13-day old embryonated eggs were infected with Lee virus, 3 X 104 
EIDs0/ml, and incubated for 41 h. Untreated membranes showed no macroscopic damage. 
Macroscopic damage  was estimated as described  previously (4). 
comparable  to  that  of  the  5-methoxy-l-methyl  compound,  the  maximal 
tolerated concentration is  lower,  and  therefore maximal obtainable enhance- 
ment is also lower. 
In experiments carried out in membranes from 11- or 13-day old embryonated 
eggs,  the  1-fl-D-ribofuranoside of 5-methoxybenzimidazole (1.75  and 3.5 raM) 
showed lower enhancing activity than 5-methoxy-l-methylbenzimidazole. The 
1-/~-9-ribofuranoside of 6-methoxybenzimidazole (0.875  and 1.75 raM) showed 
less  inhibitory  activity  than  6-methoxy-l-methylbenzimidazole.  No  gross 
damage to membranes was noted. 
Enhancing  Action  of  5-Methoxy-l-methylbenzimidazole.--The  action  of  5- 
methoxy-l-methylbenzimidazole as  a  representative  of  a  new  group  of  en- 
hancers of Lee virus multiplication was investigated in detail and compared 
with that of 5-methyl-l-D-ribobenzimidazole (MRB) (1, 2). 
Dependence of enhancement on age of membranes: Table IV shows that 1.75 mM 
5-methoxy-l-methylbenzimidazole caused only a  small percentage increase in 
the very high yield of Lee virus in chorioallantoic membranes from 8-day old 866  ENHANCERS  OF  INFLUENZA VIRUS MULTIPLICATION 
TABLE  IV 
Dependence of Enhancement of Lee Virus Multiplication  by 5-Methoxy-l-methylbenzimidazole 
on Age of Chorioallantoic Membrane 
Age of chorioallantoic  Control 
membrane 
Yield of virus in chorloallantoic  membrane 
in vitro, HAU/ml* 
5-Methoxy-l-methyl-  Increase in treated 
benzimidazole, 1.75 raM  cultures 
days  % 
8  323  422  31 
10  75  172  129 
13  28  157  406 
* Cultures were infected with Lee virus, 3 X 104 EIDs0/ml, and incubated for 41 h with or 
without 5-methoxy-l-methylbenzimidazole.  Mean of two experiments. 
embryonated chicken eggs. The increase was greater in 10-day old membranes, 
and greatest (406 %) in 13-day old membranes, in which the control yield after 
a small virus inoculum was approximately 1/10th of that in membranes from 
8-day old embryonated eggs. In absolute terms, 1.75 mM 5-methoxy-l-methyl- 
benzimidazole made possible the production of an additional amount of 97-129 
HAU of virus in the chorioallantoic membranes of varying age. 
The  relationship  between  age  of  chorioallantoic  membrane  and  degree  of 
enhancement of Lee virus yield by 5-methoxy-l-methylbenzimidazole is closely 
similar to that previously described for MRB  (1, 2). 
Relationship  between yields in  control  and  treated cultures:  Fig.  6  shows the 
relationships  between yield in  controls  and percent  enhancement in  cultures 
treated with 1.75 mM 5-methoxy-l-methylbenzimidazole. The data are derived 
from 20 experiments carried out with membranes from 13-day old embryonated 
eggs between August 22,  1970,  and October 17,  1972.  Each culture contained 
portions of chorioallantoic membrane from 12 embryonated eggs (2), and thus 
each point records the mean result for chorioallantoic membranes from a group 
of 12  embryos. It is apparent that percent increase in Lee virus yield in the 
presence  of  5-methoxy-l-methylbenzinfidazole  is  inversely  related  to  the 
control  yield,  although  biological variation is considerable.  The  grand mean 
yields were as follows: control, 28 HAU/ml; treated,  166 HAU/ml. Thus 1.75 
mM 5-methoxy-l-methylbenzimidazole caused, on the average, a 490 % increase 
in virus yield. This compares with a 650 % increase in a large series of separate 
experiments with 3.5 mM 5-methyl-2-D-ribobenzimidazole (2). With the latter 
compound, too, percent increase in yield in treated cultures is inversely related 
to control yield (1). 
The  relationship  between  control  yield  and  degree  of  enhancement  by 5- 
methoxy-l-methylbenzimidazole was also investigated in chorioallantoic mem- 
branes from individual chicken embryos. 
Six 13-day  old embryonated eggs  were selected at random and from each membrane nine 1.9 
cm 2 portions were punched out and distributed among three cultures, as follows: control, 5- IGOR  TA~  867 
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yield in the presence of 1.75 mM 5-methoxy-l-methylhenzimidazole. For procedure see Fig. 1. 
Results of 20 experiments. 
methoxy-l-methylbenzimidazole  (1.75 mM), and MRB  (3.5 mM). Each culture contained 5.7 
cm ~ of membrane in 3.0 ml of medium and 9  X  104 EIDs0 of Lee virus as the inoculum. The 
cultures were incubated for 41 h and the yield of virus was determined by hemagglutination 
titration of the medium. Three such experiments were carried out, on these dates: July 20 and 
27, and August  10,  1971. In the fourth experiment on September 7,  1971, the procedure was 
varied to include two control cultures, as well as one culture with each of the two compounds. 
For this experiment eight 1.9 cm 2 portions of membrane were obtained from each of six em- 
bryonated eggs, and each culture contained 3.9 cm 2 of membrane in 2 ml of medium and 6  X 
104 EID50 of Lee virus as the inoculum. 
Fig. 7 shows that similar  results were  obtained  with  the 5-methoxy-l-meth- 
ylbenzimidazole and MRB used at nearly equivalent  enhancing  concentra- 
tions.  With both compounds the degree  of enhancement  is  inversely  related 
to  the  control  yields  in  the  membranes  from  individual  chicken  embryos. 
There  are,  however,  some  low  yielders,  whose  capacity  to  make  virus  is 
not markedly enhanced by the benzimidazole  derivatives, and a few fairly high 
yielders, which are able to make even more virus in response  to the compounds. 
The grand mean yields from  the four experiments  were:  control,  41  HAU/ml; 
5-methoxy-l-methylbenzimidazole  (1.75 raM),  111  HAU/ml; and MRB  (3.5 
raM), 105 HAU/ml. The mean yield values for treated  cultures from the  four 868  ENHANCERS  OF  IN]?LUENZA  VIRUS  MULTIPLICATION 
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experiments gave the following virus yield ratios, 
5-methoxy-l-methylbenzimidazole 
:  1.15;  1.13;  1.08;  and  0.96. 
5-methyl-l-D-ribobenzimidazole 
Among the 24 individual embryonated eggs studied, close correspondence in responses to 
the two derivatives was observed in membranes from  17 eggs.  With these  17  embryos, the 
yields in cultures derived from the same membrane and treated with one or the other com- 
pound were within a 1.4-fold range of each other, and variation appeared to be random. In two 
membranes,  the  virus  yield  ratios,  5-methoxy-l-methylbenzimidazole/5-methyl-2-D-ribo- 
benzimidazole, were  1.69  and  1.78  and in remaining five,  the yield ratios were  0.37,  0.34, 
0.50,  0.44,  and 0.52.  In these comparisons, allowance was made for the differences between 
computed mean yields in cultures treated with the two compounds. 
These results suggest that  there is no systematic  difference in the responses 
of membranes  from individual  chicken embryos  to  the enhancing effects of 5- 
methoxy-l-methylbenzimidazole  and MRB  on Lee virus multiplication. Control 
experiments described below substantiate  this view. 
Three control experiments were carried out in which triplicate untreated cultures were set 
up from individual eggs.  Six embryonated eggs  were used for each experiment. Each of the IGOR  TAMM  869 
three cultures prepared  from the same chorioallantoic membrane contained three 1.8 cm 2 por- 
tions of membrane in 3 ml of medium. The dates were: August 3, October 26,  and December 
28,  1971.  In  addition,  results  in  duplicate controls  were available from  the  experiment  of 
September 7,  1971.  With the chorioallantoic membranes from the 24 embryonated eggs  ex- 
amined, the yields among replicate groups were within a  1.4-fold  range of each other in 20 of 
the eggs. In the remaining four, the yields in triplicate groups from membranes of the individual 
eggs were as follows: 20, 16, 25;  16, 40, 40; 40, 80,  100; and 40,  32, 28 HAU/ml. The greatest 
difference  between yields in any two groups from the same membrane was 2.5-fold.  The great- 
est difference  between yields from different  membranes was 74-fold.  The yields in triplicate 
control cultures from the membrane that produced the least virus were 2.5, 2, and 2 HAU/ml; 
the yields from the highest producer were 160,  160,  and 160 HAU/ml. 
The relationship between virus yield in controls and degree of enhancement 
was also investigated with 3.5 mM 5-methoxy-l-methylbenzimidazole and the 
results were similar to those obtained with the compound at 1.75 mM concen- 
tration. 
Effects of pre- and posttreatment: Results of experiments summarized in Table 
V  show  that  cultures  pretreated  with  5-methoxy-l-methylbenzimidazole  for 
17 h,  and  then  washed  thoroughly to  remove  the compound,  produced  con- 
siderably more virus than cultures not treated at any time. However, treatment 
with 5-methoxy-l-methylbenzimidazole both before and after infection gave a 
greater increase in Lee virus yield than treatment before or after infection only. 
To  obtain  maximal  enhancement,  prolonged  treatment  with  5-methoxy-1- 
methylbenzimidazole, as with MRB  (2), is necessary. 
Effect of combined treatment: Similarities in the virus-enhancing effects  of 5- 
methoxy-l-methylbenzimidazole  and  MRB  suggested  that  the  action  of  the 
two compounds may be additive in combined treatment. Results in Table VI 
TABLE  V 
Enhancing  Effects  of Pre- and Posttreatment  with 5-Methoxy-l-methylbenzimidazole  and 
5-Methyl-g-D-ribobenzimidazole  on Virus  Yield 
Yield of virus in chorioallantoic  Period of treatment from beginning of experiment*  membrane in vitro¢ 
Before infection  After infection  HAU/ml  Increase  in  treated cultures 
h  h  % 
0-17  17-64 
Control  Control  22  -- 
5-Methoxy-l-methyl  Control  61  177 
5-Methyl-2-n-ribo  Control  79  259 
Control  5-Methoxy-l-methyl  135  514 
Control  5-Methyl-2-n-ribo  101  359 
5-Methoxy-l-methyl  5-Methoxy-l-methyl  192  773 
5-Methyl-2-D-ribo  5-Methyl-2-D-ribo  180  818 
* Membranes from  13-day old embryonated eggs were infected with Lee virus,  3  X  104 
EID50/ml.  Control refers  to medium without 5-methoxy-l-methylbenzimidazole  (1.75 mM) 
or 5-methyl-2-9-ribobenzimidazole  (3.5 raM): 
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TABLE  VI 
Effect of Combined Treatment with 5-Methoxy-l-methylbenzimidazole and  5-Methyl-2-D- 
ribobenzimidazole on Virus Yield 
Treatment 
Yield of virus in chorioallantoic 
membrane in vitro* 
HAU/ml  Increase  in  treated cultures 
% 
Control  74  -- 
5-Methoxy-l-methyl, 0.88 mM  357  382 
5-Methyl-2-D-ribo, 1.75 mM  226  205 
5-Methoxy-l-methyl, 0.88 mM +  5-methyl-2-D-ribo,  1.75 mM  501  577 
* Membranes from 13-day  old embryonated eggs  were infected with Lee virus, 104.  s EIDs o/ 
ml, and incubated for 41 h. Mean of two experiments. 
show that the combined effect of 0.88 mM 5-methoxy-l-methylbenzimidazole 
plus 1.75 mM MRB is equivalent to the sum of the effects of either compound 
alone. 
Enhancing  effect in chorioallantoic  membranes from COFAL-negative embryos: 
Chorioallantoic membranes from 13-day old COFAL-negative chick embryos, 
obtained from Spafas, Inc., Norwich,  Conn., produce smaller amounts of Lee 
virus than membranes from eggs produced by the random-bred flock at Sham- 
rock Farms, North Brunswick, N. J. (2). Although both flocks consist of White 
Leghorn hens, the flocks are genetically different. In an experiment with mem- 
branes from 18 individual  COFAL-negative eggs,  the  mean yield in  controls 
was  <2  HAU/ml,  while  the  yield  in  membranes  treated  with  1.75 mM  5- 
methoxy-l-methylbenzimidazole was  48.  Similar  results  have  been  obtained 
with MRB  (2). 
DISCUSSION 
We have found no marked differences in the enhancing activity of a group of 
polyhydroxyalkyl-benzimidazoles on  influenza  B  (Lee)  virus  multiplication. 
Examined in chorioaltantoic membranes from 10-day old chicken embryos, the 
derivatives caused a 150 % increase in virus yield at concentrations in the range 
from 1.5 to 1.9 raM. It appears that neither the overall molecular configuration 
of polyhydroxyalkyl-benzimidazoles, nor all of its details are critically impor- 
tant for enhancing activity. However, the presence of the hydroxyl groupings 
in the side chain attached at position 2 in the benzimidazolyl nucleus is critically 
important for enhancing activity, as 5-methyl-2-butylbenzimidazole is a highly 
active inhibitor  (5).  This  derivative,  which  has  a  four-membered alkyl  side 
chain at position 2, causes 75 % reduction in influenza virus yield at a concen- 
tration of 0.17 mM. 
One  compound in  this  group,  i.e.  5-methyl-2-D-ribobenzimidazole (MRB), 
has been studied extensively in previous work (1, 2). In membranes from 13-day IGOR  TAMM  871 
old embryos, 3.5 mM 5-methyl-2-D-ribobenzimidazole increases virus yield by 
650%, on the average. At 5.2 mM concentrations, which is the concentration 
causing peak enhancement, the increase in virus yield is 1.4 times greater than 
at 3.5 raM.  This gives an estimated average peak enhancement of 910%  for 
this compound. 
Members of a new group of enhancers show marked dependence of the ac- 
tivity on molecular structure, and the enhancing activity of several members of 
the new group exceeds that of MRB. 5-Hydroxy-l-methylbenzimidazole (Fig. 
8) is the derivative that produces the greatest increase in Lee virus yield after 
a small inoculum in chorioallantoic membranes from 13-day old embryonated 
eggs. We estimate that the maximal effect obtainable with this compound at 
the optimal concentration of 3.3 mM is 3.4 times greater than that obtained 
with MRB, and is equivalent to a  30-fold increase, on the average, over the 
control yield in untreated cultures. 
A review of Figs. 1-5 and Table III suggests that two factors determine the 
I 
CH  3 
FIG. 8. The structure of 5-hydroxy-l-methylbenzimidazole--a  highly  active enhancer of in- 
fluenza  virus multiplication (tool wt 148.16). 
dose-effect curves  observed:  (a)  the  specific  enhancing activity of  the  com- 
pounds, and (b)  toxicity. According to specific activity, the rank order of the 
derivatives  is  as  follows:  6-hydroxy-l-methyl  >  5-hydroxy-l-methyl  >  5- 
methoxy-l-methyl >  5-methyl-2-x)-ribo;  no exact rank assignment is possible 
for  6-methoxy-l-methylbenzimidazole. The  rank  order  based  on  maximal 
enhancement at the highest tolerated concentration is different: 5-hydroxy-1- 
methyl >  5-methoxy-l-methyl >  5-methyl-2-D-ribo >  6-hydroxy-l-methyl > 
6-methoxy-l-methyl. The hydroxyl grouping either at position 5 or 6 in the 
benzimidazolyl nucleus is clearly superior to the methoxyl grouping in that the 
hydroxy derivatives display both higher specific activities and higher tolerated 
dose levels than the corresponding methoxy compounds. Substitution at posi- 
tion 5 is much superior to substitution at position 6 insofar as the tolerated dose, 
and therefore the maximal possible enhancing effect is concerned, but the highest 
specific enhancing activity was displayed by the 6-hydroxy-l-methyl derivative. 
To summarize the central findings: the high maximal enhancement obtain- 
able with 5-hydroxy-l-methylbenzimidazole can be ascribed to two factors: (a) 
the  hydroxyl grouping at position 5  in  the  benzimidazolyl nucleus imparts 
enhancing activity in high degree; (b) the methyl grouping at position 1 reduces 872  ENHANCERS  OF  INFLUENZA  VIRUS  MULTIPLICATION 
the  toxicity of  the  benzimidazole  moiety.  The  hydroxyl  grouping  imparts 
enhancing activity of a high order also when substituted at position 6, however 
such substitution is associated with toxicity that vitiates the enhancing  effect. 
All these considerations apply also to 5-methoxy-l-methylbenzimidazole, with 
the qualification that the methoxyl grouping is inferior to the hydroxyl grouping 
in  imparting  enhancing  capability  to  the  molecule.  The  relative  enhancing 
activities of the derivatives are given in Table VII. 
Although  the 5-hydroxy-l-methyl derivative is the  compound of  choice in 
studies of influenza virus enhancement, our investigation of the action  of the 
new group of enhancers has so far been carried out with the 5-methoxy-l-methyl 
derivative. The evidence obtained to date has not revealed any differences in 
the  actions  of 5-methoxy-l-methylbenzimidazole and  MRB.  The  enhancing 
effect of both compounds can be characterized as restoration of the capacity of 
TABLE VII 
Relative Enhancing  Activity of Benzimidazole Derivatives on Influenza B  (Lee) Virus 
Multiplication 
Relative activity  Re]ative activity based 
Peak enhancing  based on equivalent 
Benzirnidazole  derivative  concentration  enhancing concen-  on maximal enhancing 
tration  effect 
mM 
5-Methyl-2-D-ribo  5.2  1  1 
5-Methoxy-l-methyl  2.5  2.6  1.4 
5-Hydroxy-l-methyl  3.3  4.3  3. a 
6-Methoxy-l-methyl  0.1  --  < 1 
6-Hydroxy-l-methyl  0.8  6.7  < 1 
membranes  from older chicken  embryos to  produce  large  amounts  of virus 
after a small inoculum of Lee virus. Both compounds are able to increase virus 
yield when used to pretreat membranes, but their effect is greatest when pre- 
treatment is followed by prolonged treatment after infection. There is marked 
variation in control yields from membranes of individual  embryonated eggs 
derived from random-bred flocks of White Leghorn hens.  No significant dif- 
ferences, exceeding experimental variation, have been found in the responses of 
individual membranes to 5-methoxy-l-methylbenzimidazole and MRB, which 
supports the view that the two compounds act by the same mechanism. The 
fact that combined treatment with the two compounds gives an additive effect 
also supports this possibility. 
The nature  of the mechanism  by which  certain benzimidazole derivatives 
increase the yield of influenza virus in the chorioallantoic membrane is not yet 
clear. In early work (1), two possibilities were considered to explain the virus- 
enhancing action of 5-methyl-2-D-ribobenzimidazole: (a)  the compound, or a 
conversion product thereof in cells, may serve as a metabolite; (b) the compound IGOR  TAMM  873 
may interfere with  certain normal  cell functions.  In  a  recent report  (2)  the 
action of MRB was viewed as overcoming a virus-restrictive mechanism that is 
expressed in the course of embryological development. It was suggested that the 
compound may improve the functional capabilities of some cellular structure 
required in influenza virus multiplication or that it may block an endogenous 
virus inhibitor. 
It is of interest to note that, while nontoxic for the chorioallantoic membrane, 
3.5 InM  MRB  causes  morphological changes  in  monolayer cultures  derived 
from trypsinized membranes  (2)  or rhesus monkey kidneys  (6)  and  reduces 
influenza virus yield. The virus-enhancing action in the chorioallantoic mem- 
brane thus clearly depends on the physiological state of the developing chick 
embryo. 
SUMMARY 
The  enhancing  activity of 5-methyl-2-D-ribobenzimidazole on influenza B 
(Lee) virus yield in chorioallantoic membranes from 10-day old embryonated 
eggs was compared with that of eight other polyhydroxyalkyl-benzimidazoles. 
No marked differences in activity were noted with the following six derivatives: 
5,6-dimethyl-2-D-ribo; 2-D-gluco;  5-methyl-2-D-gluco; 5,6-dimethyl-2-D-gluco; 
5-methyl-2-D-galacto; and  5-methyl-2-L-rhamno. None  caused  morphological 
damage to the membranes at a concentration of 3.5 raM. The solubility of the 
5-methyl-2-D-arabo and 5-methyl-2-D-manno derivatives was too low to permit 
quantitative comparisons, but both were active and nontoxic at a  concentra- 
tion of 1.75 rnM. 
5-Hydroxy-l-methylbenzimidazole  and  5-methoxy-l-methylbenzimidazole 
are  more  active  than  5-methyl-2-n-ribobenzimidazole both  with  respect  to 
specific activity and maximal enhancement at the highest tolerated dose. The 
hydroxyl substituent  is  superior  to  the  methoxyl grouping.  Substitution  at 
position 5 is superior to substitution at position 6 with respect to the tolerated 
dose level and therefore the maximal effect obtainable, but the 6-hydroxy-1- 
methyl derivative showed the highest specific activity. 
5-Methoxy-l-methylbenzimidazole increases the yield to a comparable extent 
as measured by infectivity and hemagglutination titrations. The responses of 
membranes  from individual  chicken  embryos to  the  enhancing  action  of 5- 
methoxy-l-methylbenzilnidazole and 5-methyl-2-D-ribobenzimidazole are simi- 
lar.  5-Methoxy-l-methylbenzimidazole restores  the  capacity  of  membranes 
from older chicken embryos to produce a large amount of virus after a small 
inoculum. This derivative increases the yield of virus in membranes  treated 
before infection only. Maximal enhancement is obtained with prolonged treat- 
ment,  starting  before,  and  continuing  after  infection.  5-Methoxy-l-methyl- 
benzimidazole increases the yield of virus from COFAL-negative embryos in 
which the control yield is very low. Combined treatment with moderate doses 874  ENHANCERS  OF  INFLUENZA  VIRUS  MULTIPLICATION 
of 5-methoxy-l-methytbenzimidazole and 5-methyl-2-D-ribobenzimidazole  gives 
an additive effect. 
The author wishes to thank Miss Huguette Viguet for excellent technical assistance in the 
performance  of this study. 
APPENDIX 
Additional  evidence that substitution of a methyl group at position 1 in the benzimi- 
dazole nucleus reduces influenza virus-inhibitory activity and  cytotoxicity has been 
obtained with the 5-chloro and 5-chloro-l-methyl derivatives. The  75%  virus-inhibi- 
tory concentration of 5-chlorobenzimidazole is 0.75 mM (3, 4), but that of 5-chloro-1- 
methylbenzimidazole is 3.2 raM. 5-Chlorobenzimidazole causes 4-1- macroscopic dam- 
age at 3.0 mM, and 1 +  at 1 mM (4),  whereas 5-chloro-l-methylbenzimidazole causes 
1 +  damage at 3.5 mM,  and 0 damage at 2.3  mM.  Quantitative  comparison of  the 
virus-inhibitory activity and  toxicity of the 5,6-dichloro and 5,6-dichloro-l-methyl 
derivatives is not possible because of the poor solubility of these compounds, however 
the 75 % virus-inhibitory concentation of 5,6-dichlorobenzimidazole is ~0.25 mM (3), 
whereas that of 5,6-dichloro-l-methylbenzimidazole  is 0.48 mM. 
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